Trajectories of maternal depressive and anxiety symptoms from pregnancy to five years postpartum and their prenatal predictors.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
14 Jan 2019
Historique:
received: 12 10 2018
accepted: 04 01 2019
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 7 5 2019
Statut: epublish

Résumé

Maternal depression and anxiety have distinct constellations of symptom trajectories, which are associated with factors that may vary between different groups of women. The aim of this study was to identify subgroups of women who exhibit unique longitudinal trajectory patterns of depressive and anxiety symptoms from pregnancy to 5 years postpartum and the antenatal predictors associated with these maternal groups. The study used a longitudinal data collected from 615 women in Saskatchewan from pregnancy to 5 years postpartum. Semiparametric group-based models were used to identify latent maternal depressive and anxiety trajectory groups. Multinomial logit models were then used to assess the association between maternal characteristics and the identified latent trajectory groups. We identified four trajectory groups of maternal depressive symptoms: low-stable (35%); moderate-stable (54%); moderate-increasing (5%); and high-decreasing (6%), and three trajectory groups of maternal anxiety symptoms: very low-stable (13%); low-stable (58%); and moderate-stable (29%). We also identified several risk factors, most notably history of depression and stress, that were significantly associated with these trajectories. History of depression and increased stress are significant risk factors that can be identified during regular perinatal visits; therefore, clinicians should inquire about these risk factors to identify women at high risk of ongoing depression or anxiety.

Sections du résumé

BACKGROUND BACKGROUND
Maternal depression and anxiety have distinct constellations of symptom trajectories, which are associated with factors that may vary between different groups of women. The aim of this study was to identify subgroups of women who exhibit unique longitudinal trajectory patterns of depressive and anxiety symptoms from pregnancy to 5 years postpartum and the antenatal predictors associated with these maternal groups.
METHODS METHODS
The study used a longitudinal data collected from 615 women in Saskatchewan from pregnancy to 5 years postpartum. Semiparametric group-based models were used to identify latent maternal depressive and anxiety trajectory groups. Multinomial logit models were then used to assess the association between maternal characteristics and the identified latent trajectory groups.
RESULTS RESULTS
We identified four trajectory groups of maternal depressive symptoms: low-stable (35%); moderate-stable (54%); moderate-increasing (5%); and high-decreasing (6%), and three trajectory groups of maternal anxiety symptoms: very low-stable (13%); low-stable (58%); and moderate-stable (29%). We also identified several risk factors, most notably history of depression and stress, that were significantly associated with these trajectories.
CONCLUSION CONCLUSIONS
History of depression and increased stress are significant risk factors that can be identified during regular perinatal visits; therefore, clinicians should inquire about these risk factors to identify women at high risk of ongoing depression or anxiety.

Identifiants

pubmed: 30642277
doi: 10.1186/s12884-019-2177-y
pii: 10.1186/s12884-019-2177-y
pmc: PMC6332639
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : CIHR
ID : 145179 and 220896
Organisme : CIHR
ID : 145179 and 220896

Références

J Affect Disord. 2013 Apr 5;146(2):224-30
pubmed: 23116811
J Affect Disord. 2011 Dec;135(1-3):128-38
pubmed: 21802737
J Clin Psychiatry. 2016 Nov;77(11):e1467-e1473
pubmed: 28076674
J Psychiatr Res. 2001 Mar-Apr;35(2):95-104
pubmed: 11377438
Soc Sci Res. 2012 Nov;41(6):1546-64
pubmed: 23017973
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006116
pubmed: 17943888
Issues Ment Health Nurs. 2012 Jul;33(7):445-57
pubmed: 22757597
Am J Obstet Gynecol. 2010 Jan;202(1):5-14
pubmed: 20096252
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
PLoS One. 2014 Jan 22;9(1):e86653
pubmed: 24466190
J Subst Abuse Treat. 2015 Sep;56:34-8
pubmed: 25841705
Can J Psychiatry. 2012 Mar;57(3):161-7
pubmed: 22398002
Psychol Med. 2015 Jul;45(9):1999-2012
pubmed: 25678201
Depress Anxiety. 2008;25(9):793-800
pubmed: 17397041
Arch Womens Ment Health. 2015 Feb;18(1):73-84
pubmed: 25352316
Encephale. 2004 Jul-Aug;30(4):376-81
pubmed: 15538313
J Abnorm Psychol. 2009 Aug;118(3):479-93
pubmed: 19685946
J Clin Psychiatry. 2000;61 Suppl 10:16-24
pubmed: 10910013
J Geriatr Psychiatry Neurol. 2014 Jun;27(2):94-102
pubmed: 24584465
BMC Psychiatry. 2009 Jun 01;9:31
pubmed: 19486530
Dev Psychol. 2007 Sep;43(5):1202-15
pubmed: 17723045
J Affect Disord. 2017 Dec 1;223:194-208
pubmed: 28763638
Dev Psychopathol. 2009 Winter;21(1):139-56
pubmed: 19144227
J Womens Health (Larchmt). 2011 May;20(5):711-8
pubmed: 21426237
Obstet Gynecol. 2015 May;125(5):1268-1271
pubmed: 25932866
J Affect Disord. 2012 Jun;139(1):23-9
pubmed: 22410506
Arch Womens Ment Health. 2003 Feb;6(1):51-7
pubmed: 12715264
J Affect Disord. 2013 Jun;148(2-3):347-51
pubmed: 23380518
Lancet Psychiatry. 2015 Jan;2(1):59-67
pubmed: 26359613
J Affect Disord. 2016 Jun;197:125-33
pubmed: 26991367
Psychol Med. 2018 May;48(7):1139-1147
pubmed: 28889814
J Affect Disord. 2009 Dec;119(1-3):116-23
pubmed: 19342104
J Affect Disord. 2011 Jun;131(1-3):277-83
pubmed: 21269708
J Affect Disord. 2015 Jan 1;170:30-8
pubmed: 25218734
Can J Psychiatry. 2008 Jul;53(7):435-40
pubmed: 18674401

Auteurs

Asma Ahmed (A)

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Purvis Hall, 1020 Pine Avenue W, Room 27, Montreal, Quebec, H3A 1A2, Canada. asma.ahmed2@mail.mcgill.ca.

Angela Bowen (A)

College of Nursing, University of Saskatchewan, 104 Clinic Place, Health Sciences Building, Room 4246, Saskatoon, Saskatchewan, S7N 2Z4, Canada.

Cindy Xin Feng (CX)

School of Public Health, University of Saskatchewan, 104 Clinic Place, Health Sciences Building, Room 3338, Saskatoon, Saskatchewan, S7N 2Z4, Canada.

Nazeem Muhajarine (N)

College of Medicine, University of Saskatchewan, 104 Clinic Place, Health Sciences Building, Room 3246, Saskatoon, Saskatchewan, S7N 2Z4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH